Kolon Life Science Inc (102940) — Cash Flow Quality Index
Kolon Life Science Inc (102940) has a Cash Flow Quality Index of 0.10x as of September 2025. Operating cash flow of ₩2.58 Billion is below net income of ₩25.54 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 102940 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kolon Life Science Inc Cash Flow Quality Index (2011–2022)
Historical Cash Flow Quality Index for Kolon Life Science Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Kolon Life Science Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Kolon Life Science Inc (2011–2022)
Year-by-year earnings quality comparison for Kolon Life Science Inc. For live market cap and the full company financial profile, see 102940 stock market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -9.78x | ₩-20.85 Billion | ₩2.13 Billion | ▼ -540.4% |
| 2016 | 2.22x | ₩28.11 Billion | ₩12.67 Billion | ▼ -91.5% |
| 2015 | 26.00x | ₩20.81 Billion | ₩800.14 Million | ▲ +1158.9% |
| 2014 | 2.07x | ₩12.10 Billion | ₩5.86 Billion | ▲ +67.1% |
| 2012 | 1.24x | ₩23.37 Billion | ₩18.90 Billion | ▲ +18.5% |
| 2011 | 1.04x | ₩11.65 Billion | ₩11.17 Billion | — |